Narcolepsy trials in Canada

In Canada 7 Also abroad 43

7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Where
Markham, Toronto
Age
18 years to 70 years
People
150 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT07455383
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Where
Markham, Toronto
Age
18 years to 70 years
People
176 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT07502443
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Where
Markham, Toronto
Age
18 years to 70 years
People
150 worldwide
Run by
Alkermes, Inc.
See details and how to joinNCT07540897
Phase 3Taking people
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Where
Markham, Toronto
Age
18 years and over
People
258 worldwide
Run by
Harmony Biosciences Management, Inc.
See details and how to joinNCT07675135 · EU 2025-523821-17-00
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Where
Calgary, Markham, Ottawa, Toronto
Age
18 years and over
People
64 worldwide
Run by
Eisai Inc.
See details and how to joinNCT07493265
Phase 2Taking people
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Where
Toronto
Age
18 years to 65 years
People
248 worldwide
Run by
Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT06752668 · EU 2024-518929-15-00
Phase 2Taking people
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Where
Toronto
Age
18 years to 65 years
People
90 worldwide
Run by
Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT07096674 · EU 2025-522987-34-00